Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

Citation(s) in RCA

1
(from Reference Citation Analysis)

Indexed Articles

Ranked By

Results Analysis

Year Published Analysis
Article Type Analysis
Journal Title Analysis
Category Analysis

Results Analysis

Year Published

Show more Refine

Article Statistics

Refine

Publication Titles

Show more Refine

Category

Show more Refine

For: Olencki T, Budd GT, Murthy S, Finke J, Herzog P, McLain D, Tubbs R, Tuason L, Edinger M, Levitt D, Bukowski RM. Phase IA/IB Trial of rhIL-6 in Patients with Refractory Malignancies: An Immunomodulatory Cytokine. J Immunother 1993. [DOI: 10.1097/00002371-199311000-00036] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]

For:	Olencki T, Budd GT, Murthy S, Finke J, Herzog P, McLain D, Tubbs R, Tuason L, Edinger M, Levitt D, Bukowski RM. Phase IA/IB Trial of rhIL-6 in Patients with Refractory Malignancies: An Immunomodulatory Cytokine. J Immunother 1993. [DOI: 10.1097/00002371-199311000-00036] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]

Number

Cited by Other Article(s)

Seymour JF, Kurzrock R. Interleukin-6: biologic properties and role in lymphoproliferative disorders. Cancer Treat Res 1996;84:167-206. [PMID: 8724631 DOI: 10.1007/978-1-4613-1261-1_9] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]